2024. Half-life-extended Monoclonal Antibody APG777 for Atopic Dermatitis: Design of the Phase 2 APEX Study. SKIN The Journal of Cutaneous Medicine. 8, 6 (Nov. 2024), s456. DOI:https://doi.org/10.25251/skin.8.supp.456.